Agency Forms Undergoing Paperwork Reduction Act Review, 18595 [2013-07041]

Agencies

• Centers for Disease Control and Prevention
• DEPARTMENT OF HEALTH AND HUMAN SERVICES

[Federal Register Volume 78, Number 59 (Wednesday, March 27, 2013)]
[Notices]
[Page 18595]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-07041]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[30Day-13-0745]


Agency Forms Undergoing Paperwork Reduction Act Review

    The Centers for Disease Control and Prevention (CDC) publishes a 
list of information collection requests under review by the Office of 
Management and Budget (OMB) in compliance with the Paperwork Reduction 
Act (44 U.S.C. Chapter 35). To request a copy of these requests, call 
the CDC Reports Clearance Officer at (404) 639-7570 or send an email to 
omb@cdc.gov. Send written comments to CDC Desk Officer, Office of 
Management and Budget, Washington, DC or by fax to (202) 395-5806. 
Written comments should be received within 30 days of this notice.

Proposed Project

    Colorectal Cancer Screening Program (OMB No. 0920-0745, exp. 6/30/
2013)--Extension--National Center for Chronic Disease Prevention and 
Health Promotion (NCCDPHP), Centers for Disease Control and Prevention 
(CDC).

Background and Brief Description

    Of cancers affecting both men and women, colorectal cancer (CRC) is 
the second leading cause of cancer-related deaths in the United States. 
Based on scientific evidence which indicates that regular screening is 
effective in reducing CRC incidence and mortality, regular CRC 
screening is now recommended for adults starting at age 50 and 
continuing until age 75 years.
    In 2005, CDC established a three-year demonstration program, 
subsequently extended to four years, to screen low-income individuals 
50 years of age and older who have no health insurance or inadequate 
health insurance for CRC. The five demonstration sites reported 
information to CDC including de-identified, patient-level demographic, 
screening, diagnostic, treatment, outcome and cost reimbursement data 
(OMB No. 0920-0745, exp. 7/31/2010). The information has been used to 
assess the feasibility and cost effectiveness of a publically funded 
screening program, describe key outcomes, and guide the expansion of 
the program. In 2009, with the conclusion of the demonstration program 
and increased Congressional funding to continue support of a colorectal 
cancer screening program, CDC established the Colorectal Cancer Control 
Program (CRCCP) to fund 26 sites for a five-year program period to 
increase population-based CRC screening and reduce health disparities 
in CRC screening, incidence and mortality. Funded sites implement 
evidence-based interventions to increase population-level screening 
rates. To address disparities in access to screening, funded sites 
screen low-income individuals 50 years of age and older who have no 
health insurance or inadequate health insurance for CRC. The funded 
sites report information to CDC including programmatic-level activity 
cost data, and de-identified patient-level demographic, screening, 
diagnostic, treatment and outcome data (OMB No. 0920-0745, exp. 6/30/
2013).
    CDC is requesting OMB approval to continue the information 
collection for an additional three years. CDC will collect de-
identified Colorectal Clinical Data Elements (CCDE) on services 
provided to low-income individuals age 50 and older with inadequate or 
no health insurance. CDC will use the information to monitor and 
evaluate the program and funded sites; improve the quality of screening 
and diagnostic services for underserved individuals; develop outreach 
strategies to increase screening; and report program results to 
Congress and other legislative authorities. Each site will screen an 
estimated 375 individuals per year (186 semiannually).
    The program will also collect program-level activity-based cost 
data utilizing a Cost Assessment Tool (CAT) previously used by other 
CDC-funded cancer programs. The information to be collected through the 
CAT will allow CDC to compare activity-based costs across multiple 
sites and programs, and will provide a more effective means of 
monitoring and improving the performance and cost-effectiveness of the 
CRC screening program.
    Summary CCDE information will be transmitted to CDC electronically 
twice per year. Information collected through the Cost Assessment Tool 
will be transmitted electronically to CDC once per year. Participation 
is required for all sites funded through the CRC screening program. The 
number of funded sites will increase from 26 to 29 and this will result 
in an increase in the number of respondents and total burden. There are 
no changes to the content of the information collection or the 
estimated burden per response.
    There are no costs to respondents other than their time. The total 
estimated annualized burden hours are 3,357.

                                        Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
                                                                                     Number of      Avg. burden
          Type of respondents                   Form name            Number of     responses per   per response
                                                                    respondents     respondent      (in hours)
----------------------------------------------------------------------------------------------------------------
Colorectal Cancer Screening Programs..  Clinical Data Elements..              29             375           15/60
                                        Cost Assessment Tool....              29               1              22
----------------------------------------------------------------------------------------------------------------


    Dated: March 21, 2013.
Ron A. Otten,
Director, Office of Scientific Integrity (OSI), Office of the Associate 
Director for Science (OADS), Office of the Director, Centers for 
Disease Control and Prevention.
[FR Doc. 2013-07041 Filed 3-26-13; 8:45 am]
BILLING CODE 4163-18-P